Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway

Lehe Yang(Wenzhou Medical University), Chengguang Zhao(Wenzhou Medical University)
British Journal of Cancer
October 30, 2020
Cited by 62


Related Papers